Corporate
News release
TopTokyo ― Terumo Corporation (TSE: 4543 Section 1) today announced that in the meeting of the board of directors held on April 24, 2014, it was decided to select a person below as a new candidate for independent director of the company. The new appointment will be confirmed at the annual general meeting of shareholders on June 24, 2014.
New Candidate for Independent Director
Mr. Ikuo Mori (Senior Corporate Advisor, Fuji Heavy Industries Ltd.)
Date of Birth : August 19, 1947
Business Experience
| April, 1970 : | Joined Fuji Heavy Industries Ltd. |
| June, 2002 : | Corporate Vice President,Chief General Manager of Europe Region,and Chief General Manager of Asia Pacific Region, Subaru Sales & Marketing Division |
| April, 2005 : | Corporate Senior Vice President,Chief General Manager, Subaru Overseas Sales & Marketing Division |
| June, 2006 : | Corporate Executive Vice President,Chief General Manager, Subaru Overseas Sales & Marketing Division |
| June, 2006 : | President and Chief Executive Officer,Representative Director of the Board |
| June, 2011 : | Chairman and Chief Executive Officer,Representative Director of the Board |
| June, 2012 : | Senior Corporate Advisor |
Retirement of Independent Director（as of June 24, 2014）
Mr. Masaharu Ikuta
About Terumo
Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.